Track Actuate Therapeutics's net tangible assets ($-810K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), ACTU shows a net tangible assets of $-810K. That compares with $11M in the prior-year period — down 107.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ACTU's net tangible assets is now $-810K (was $11M) — a 107.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Actuate Therapeutics is outperforming or lagging.
Tracking ACTU's net tangible assets over time shows whether Actuate Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $-810K That compares with $11M in the prior-year period — down 107.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this net tangible assets page, Stockcircle has Actuate Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $-810K) with ownership activity and broader fundamentals.